Molecular determinant of clinical response to ONC201, an inhibitor of dopamine receptor 2 (DRD2) signaling, in glioblastoma patient.

Jie Li, Jun Ma, Yuyu He, Varun Vijay Prabhu, Joshua Allen, Clark C Chen

Research output: Contribution to conference › Poster

Fingerprint

Dive into the research topics of 'Molecular determinant of clinical response to ONC201, an inhibitor of dopamine receptor 2 (DRD2) signaling, in glioblastoma patient.'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science